Literature DB >> 25001959

Effect of dietary restriction on peripheral monoamines and anxiety symptoms in obese subjects with metabolic syndrome.

Aurora Perez-Cornago1, María J Ramírez2, M Ángeles Zulet3, J Alfredo Martinez4.   

Abstract

Reduced circulating monoamines may have a role in the development of the metabolic syndrome (MetS), which is becoming a major health problem worldwide. Moreover, an association between anxiety disorder and MetS has been reported; however, it is not clear whether weight loss can diminish anxiety. This investigation is aimed to examine the effects of a weight loss intervention on peripheral monoamines levels and anxiety symptoms in subjects with metabolic syndrome (MetS). The study population encompassed subjects with MetS (age: 50±10 y.o. and BMI: 35.8±4.3 kg/m2) selected from the RESMENA study after they had completed the 6-month weight loss intervention (-30% energy). Anthropometric measurements, dietary records, anxiety symptoms, and blood monoamines levels were analysed before and after the intervention. Dopamine (DA) (+18.2%; 95% confidence interval (CI): -51.2 to -0.5) and serotonin (5-HT) (+16.1%; 95% CI: -26.3 to -2.2) blood levels were significantly increased after the intervention. Higher DA blood concentrations at the end of the study were inversely related with the carbohydrate intake during the study (B=-3.3; 95% CI: -8.4 to -0.4) and basal DA levels predicted a greater decrease in body weight and anthropometric parameters. Subjects with higher 5-HT concentrations after the weight loss intervention also showed a lower energy intake during the intervention (B=-0.04; 95% CI: -0.07 to -0.01). Additionally, anxiety symptoms decreased after the weight loss treatment (-28.3%; 95% CI: 6.2-20.4), which was parallel to a greater decrease in body weight and anthropometric markers, being related to lower 5-HT basal levels. Dietary restriction in patients with MetS may help in reducing anxiety symptoms, and also in increasing 5-HT and DA blood levels. These results provide further insights regarding emotional and neurological factors behind weight loss.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety symptoms; Diet; Dopamine; Metabolic syndrome; Peripheral monoamines; Serotonin; Weight loss

Mesh:

Substances:

Year:  2014        PMID: 25001959     DOI: 10.1016/j.psyneuen.2014.05.003

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  5 in total

Review 1.  Dopaminergic Pathways in Obesity-Associated Inflammation.

Authors:  Fernanda Leite; Laura Ribeiro
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-17       Impact factor: 4.147

2.  DNA hypermethylation of the serotonin receptor type-2A gene is associated with a worse response to a weight loss intervention in subjects with metabolic syndrome.

Authors:  Aurora Perez-Cornago; Maria L Mansego; María Angeles Zulet; José Alfredo Martinez
Journal:  Nutrients       Date:  2014-06-23       Impact factor: 5.717

3.  Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction.

Authors:  Irene Cantero; Itziar Abete; J Ignacio Monreal; J Alfredo Martinez; M Angeles Zulet
Journal:  Nutrients       Date:  2017-06-28       Impact factor: 5.717

4.  Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity.

Authors:  Fernanda Leite; Margarida Lima; Franca Marino; Marco Cosentino; Laura Ribeiro
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

5.  Predicting the naturalistic course in anxiety disorders using clinical and biological markers: a machine learning approach.

Authors:  Wicher A Bokma; Paul Zhutovsky; Erik J Giltay; Robert A Schoevers; Brenda W J H Penninx; Anton L J M van Balkom; Neeltje M Batelaan; Guido A van Wingen
Journal:  Psychol Med       Date:  2020-06-11       Impact factor: 7.723

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.